» Articles » PMID: 20225941

Challenges for Rapid Molecular HIV Diagnostics

Overview
Journal J Infect Dis
Date 2010 Mar 16
PMID 20225941
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The introduction of serological point-of-care assays 10 years ago dramatically changed the way that human immunodeficiency virus (HIV) infection was identified and diagnosed. Testing at the point of care has lead to a dramatic increase in the number of individuals who are screened and, most importantly, receive their HIV test result. As the AIDS epidemic continues to mature and scientific advances in prevention and treatment are evaluated and implemented, there is a need to identify acute (viremic preseroconversion) infections and to discriminate "window phase" infections from those that are serologically positive, especially in resource-limited settings, where the majority of vulnerable populations reside and where the incidence of HIV infection is highest. Rapid testing methods are now at a crossroads. There is opportunity to implement and evaluate the incremental diagnostic usefulness of new test modalities that are based on sophisticated molecular diagnostic technologies and that can be performed in settings where laboratory infrastructure is minimal. The way forward requires sound scientific judgment and an ability to further develop and implement these tests despite a variety of technical, social, and operational hurdles, to declare success.

Citing Articles

Development and evaluation of a high-sensitivity RT-PCR lateral flow assay for early detection of HIV-1 infection.

Sakkhachornphop S, Thongkum W, Sornsuwan K, Juntit O, Jirakunachayapisan K, Kongyai N Heliyon. 2024; 10(12):e32784.

PMID: 38975074 PMC: 11226822. DOI: 10.1016/j.heliyon.2024.e32784.


Label-free detection of synthetic, full genomic length HIV-1 RNA at the few-copy level.

Dickens O, Bajwa I, Garcia-Ramos K, Suh Y, Wen C, Cheng A Sens Actuators B Chem. 2023; 390.

PMID: 37384350 PMC: 10299804. DOI: 10.1016/j.snb.2023.134001.


False reactive HIV-1 diagnostic test results in an individual from Kenya on multiple testing platforms-A case report.

Ochola J, Imbach M, Eller L, de Souza M, Nwoga C, Otieno J IDCases. 2021; 23:e01035.

PMID: 33489756 PMC: 7808907. DOI: 10.1016/j.idcr.2020.e01035.


Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip.

Azizipour N, Avazpour R, Rosenzweig D, Sawan M, Ajji A Micromachines (Basel). 2020; 11(6).

PMID: 32570945 PMC: 7345732. DOI: 10.3390/mi11060599.


HIV Detection via a Carbon Nanotube RNA Sensor.

Harvey J, Baker H, Ortiz M, Kentsis A, Heller D ACS Sens. 2019; 4(5):1236-1244.

PMID: 31056899 PMC: 7556989. DOI: 10.1021/acssensors.9b00025.


References
1.
Obare F, Fleming P, Anglewicz P, Thornton R, Martinson F, Kapatuka A . Acceptance of repeat population-based voluntary counselling and testing for HIV in rural Malawi. Sex Transm Infect. 2008; 85(2):139-44. PMC: 2788818. DOI: 10.1136/sti.2008.030320. View

2.
Sickinger E, Jonas G, Yem A, Goller A, Stieler M, Brennan C . Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening. Transfusion. 2008; 48(4):584-93. DOI: 10.1111/j.1537-2995.2007.01583.x. View

3.
Stevens W, Noble L, Berrie L, Sarang S, Scott L . Ultra-high-throughput, automated nucleic acid detection of human immunodeficiency virus (HIV) for infant infection diagnosis using the Gen-Probe Aptima HIV-1 screening assay. J Clin Microbiol. 2009; 47(8):2465-9. PMC: 2725647. DOI: 10.1128/JCM.00317-09. View

4.
Rahangdale L, Sarnquist C, Maldonado Y, Cohan D . Patient acceptance of and satisfaction with rapid HIV Testing in a Labor and Delivery Setting. J Womens Health (Larchmt). 2008; 17(3):465-71. DOI: 10.1089/jwh.2007.0545. View

5.
Vincent M, Xu Y, Kong H . Helicase-dependent isothermal DNA amplification. EMBO Rep. 2004; 5(8):795-800. PMC: 1249482. DOI: 10.1038/sj.embor.7400200. View